3/10
08:07 am
calc
Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer [Yahoo! Finance]
Medium
Report
Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer [Yahoo! Finance]
3/5
01:37 pm
calc
CalciMedica (CALC) had its price target lowered by Oppenheimer Holdings, Inc. from $20.00 to $10.00. They now have an "outperform" rating on the stock.
Medium
Report
CalciMedica (CALC) had its price target lowered by Oppenheimer Holdings, Inc. from $20.00 to $10.00. They now have an "outperform" rating on the stock.
3/3
07:00 am
calc
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates
High
Report
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates
1/29
07:03 am
calc
CalciMedica (NASDAQ:CALC) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
High
Report
CalciMedica (NASDAQ:CALC) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.